ADC Therapeutics S.A. (ADCT) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 7 recommend buying, 4 recommend holding, and 1 recommend selling.
The analyst consensus price target for ADCT is $7.50, representing a +94.3% upside from the current price of $3.86. Price targets range from a low of $5.00 to a high of $10.00.
